Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Down 41.2% in February

Lexaria Bioscience Corp. (NASDAQ:LEXXWGet Free Report) saw a large decline in short interest in February. As of February 28th, there was short interest totalling 2,000 shares, a decline of 41.2% from the February 13th total of 3,400 shares. Based on an average daily volume of 9,100 shares, the short-interest ratio is presently 0.2 days.

Lexaria Bioscience Trading Up 29.2 %

Shares of Lexaria Bioscience stock opened at $0.26 on Friday. Lexaria Bioscience has a 1 year low of $0.16 and a 1 year high of $2.07. The firm’s 50-day moving average is $0.39 and its 200 day moving average is $0.70.

About Lexaria Bioscience

(Get Free Report)

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.

See Also

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.